Provided by Tiger Trade Technology Pte. Ltd.

CANSINOBIO

35.960
-2.040-5.37%
Volume:10.83M
Turnover:404.67M
Market Cap:8.88B
PE:279.28
High:39.680
Open:39.200
Low:35.740
Close:38.000
52wk High:52.200
52wk Low:19.220
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:2.03
T/O Rate:8.16%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.129
ROE:0.82%
ROA:-0.80%
PB:1.52
PE(LYR):279.28
PS:6.14

Loading ...

CanSino Biologics Surges Over 35% as Analysts See Parallels with Moderna's Vaccine Platform

Stock News
·
Aug 20

CLSA Says CansinoBio Shares Surge as Moderna's mRNA Cancer Vaccine Succeeds in Late-Stage Trial

Stock News
·
Aug 20

HK Movers | Pharma Stocks Surge With 3D Medicines up 68%, CanSino Biologics up 52%

Tiger Newspress
·
Aug 20

Hong Kong Stock Alert: CansinoBio Jumps 15% as mRNA Cancer Vaccine Sector Gets Major Boost

Stock News
·
Aug 20

AH Premium Rankings Unveiled: August 18 Market Close Data

Stock News
·
Aug 18

Dual-Listed Stock Premium Rankings: August 17 Closing Data

Stock News
·
Aug 17

CanSino Biologics Says China's Nmpa Accepts New Drug Application for TD5cp Adolescent and Adult

THOMSON REUTERS
·
Aug 16

CanSino Biologics: Td5cp Vaccine for Adolescents and Adults Accepted for New Drug Review

Stock News
·
Aug 16

CANSINOBIO Receives NMPA Acceptance and Priority Review for Five-Component DTaP Booster Vaccine

Bulletin Express
·
Aug 16

Dual-Listed Stock Premium Ranking: August 14 Market Close

Stock News
·
Aug 14

CANSINOBIO Reports Zero Share Capital Changes for July 2026; 860,000 H-Share Options Remain Outstanding

Bulletin Express
·
Aug 04

AH Share Premium and Deviation Data for July 20th

Stock News
·
Jul 20

CANSINOBIO Shares Surge on Regulatory Progress for Meningitis Vaccine

Stock News
·
Jul 20

CanSino Biologics Gets NMPA Nod to Review Supplemental Application Expanding Menhycia® Age Range

Bulletin Express
·
Jul 19

CansinoBIO Receives NMPA Acceptance for Age Extension of MenQuad Vaccine

Stock News
·
Jul 19

AH Share Premium and Deviation Rankings as of July 13th Close

Stock News
·
Jul 13

CANSINOBIO Sees Stable Share Capital in June 2026; Public Float Meets HKEX Requirement

Bulletin Express
·
Jul 03

AH Share Premium and Deviation Rankings for July 3rd

Stock News
·
Jul 03

CanSino Biologics Gets Registration Certificate for Meningitis Vaccine in Argentina

MT Newswires Live
·
Jun 25

CanSino Biologics: MCV4 Vaccine Gains Argentine Registration, Advancing Global Strategy

Bulletin Express
·
Jun 25